Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Proper documentation, the appropriate use of modifiers, and attention to payer-specific requirements ensure compliance and reduce administrative delays
The landmark Phase IIb clinical trial published in The Lancet (TIPO-1 study) evaluated 203 obese patients randomly assigned to receive tesofensine at doses of 0.25mg, 0.5mg, or 1.0mg daily for 24 weeks alongside an energy-restricted diet
Metabolism: It plays a role in the metabolism of lipids and folic acid
Ready to Heal and Thrive
Why Pryma Lab for Your Peptide Research
US$ 21.01
US$ 20.97
US$ 28.13
US$ 20.28
US$ 20.75
US$ 21.37
US$ 28.74
US$ 26.68
US$ 20.23
